NOT RECOMMENDED FOR PUBLICATION File Name: 24a0502n.06
Case No. 24-5513
UNITED STATES COURT OF APPEALS FOR THE SIXTH CIRCUIT
FILED Dec 06, 2024 KROGER SPECIALTY PHARMACY LA, ) KELLY L. STEPHENS, Clerk LLC; KROGER SPECIALTY PHARMACY ) HOLDINGS 2, INC., ) Plaintiffs-Appellees, ) ON APPEAL FROM THE UNITED ) STATES DISTRICT COURT FOR v. ) THE MIDDLE DISTRICT OF ) TENNESSEE GENEFIC SPECIALTY PHARMACY, INC.; ) RICHARD BROOKS MADISON, ) OPINION Defendants-Appellants.
Before: SUTTON, Chief Judge; MURPHY and BLOOMEKATZ, Circuit Judges.
SUTTON, Chief Judge. At issue is whether Richard Madison violated a noncompete
agreement with his former employer and whether his new employer, Genefic Specialty Pharmacy,
tortiously interfered with the agreement.
I.
In February 2013, a Tennessee specialty pharmacy (Total Life) hired Madison to be its
sales representative. The next year, in February 2014, another pharmacy (Modern HC Pharmacy)
purchased that company as its subsidiary.
On April 1, 2015, Madison signed a one-year noncompete and non-solicitation agreement
with Modern HC Pharmacy. The terms of the agreement prohibited Madison from competing with No. 24-5513, Kroger Specialty Pharmacies v. Genefic Specialty Pharmacy, et al.
Modern HC Pharmacy or its affiliates or successors, soliciting their customers, or recruiting their
employees.
On July 16, 2016, a Kroger-affiliated entity bought Modern HC Pharmacy. Afterward,
Modern HC Pharmacy was renamed Kroger Specialty Pharmacy Holdings 2, and its subsidiary
Total Life was renamed Kroger Specialty Pharmacy LA (referred to collectively as the Kroger
Specialty Pharmacies).
On September 15, 2023, Madison resigned. A few days later, Madison joined Genefic
Pharmacy, where he began soliciting customers of the Kroger Specialty Pharmacies and speaking
with their employees about working at Genefic Pharmacy.
Kroger learned of Madison’s activity. The Kroger Specialty Pharmacies—the successors,
recall, of Total Life and Modern HC Pharmacy—sued Madison and Genefic Pharmacy in federal
court. They raised a contract claim against Madison, a tortious-interference claim against Genefic
Pharmacy, and a trade-secrets claim against both of them.
On April 24, 2024, the district court preliminarily enjoined Madison from soliciting the
customers of the Kroger Specialty Pharmacies, recruiting their employees, or working with
Genefic Pharmacy as a representative in Tennessee, where he previously worked while employed
by the Kroger Specialty Pharmacies. The order also enjoined Genefic Pharmacy from interfering
with the agreement. Madison and Genefic Pharmacy appeal.
II.
In deciding whether to grant a preliminary injunction, courts ask whether the plaintiff is
likely to succeed, whether it will suffer irreparable harm without injunctive relief, and whether the
balance of equities and public interest favor an injunction. Winter v. Nat. Res. Def. Council, Inc.,
555 U.S. 7, 20 (2008). We review such decisions for an abuse of discretion. Arizona v. Biden, 40
2 No. 24-5513, Kroger Specialty Pharmacies v. Genefic Specialty Pharmacy, et al.
F.4th 375, 381 (6th Cir. 2022). A court abuses its discretion by misapplying the law, by using the
wrong legal standard, or by making clearly erroneous fact findings. Union Home Mortg. Corp. v.
Cromer, 31 F.4th 356, 366 (6th Cir. 2022). On appeal, Madison and Genefic Pharmacy challenge
only the district court’s likelihood-of-success determination, which we assess with fresh eyes. See
id.
As disputes about noncompete agreements go, this one has become quite narrow. None of
the conventional arguments appear. Madison and Genefic Pharmacy do not challenge the general
enforceability of the noncompete agreement. They do not argue that the provisions are unduly
restrictive in terms of duration or geographic scope. See Murfreesboro Med. Clinic, P.A. v. Udom,
166 S.W.3d 674, 678 (Tenn. 2005). They do not argue that the terms violate Tennessee public
policy. See id. They do not contest that, if the agreement applies to Madison’s actions while an
employee of Modern HC Pharmacy or its successors (the Kroger Specialty Pharmacies), he
breached the agreement. And they do not contest that, if the agreement obligates Madison vis-à-
vis the Kroger Specialty Pharmacies, that Genefic Pharmacy’s actions amounted to tortious
interference with the contract.
That leaves us with a dispute about the meaning of one aspect of the noncompete
agreement. Namely, in signing the agreement, did Madison obligate himself to Modern HC
Pharmacy and its successors, including the Kroger Specialty Pharmacies?
Tennessee law governs the dispute, as the parties agree. It says that courts, in construing a
contract, should “ascertain and give effect to the intent of the contracting parties.” Individual
Healthcare Specialists, Inc. v. BlueCross BlueShield of Tenn., Inc., 566 S.W.3d 671, 694 (Tenn.
2019). In ascertaining that intent, courts mainly look to “the written words” of the contract, “the
lodestar of contract interpretation.” Id.
3 No. 24-5513, Kroger Specialty Pharmacies v. Genefic Specialty Pharmacy, et al.
By its terms, this employment agreement binds Madison and Modern HC Pharmacy as well
as its affiliates and successors. The noncompete clause describes the employee’s and employer’s
“intent to be bound” and lists several “conditions of employment.” Vargo v. Lincoln Brass Works,
Inc., 115 S.W.3d 487, 491 (Tenn. Ct. App. 2003). The agreement says that Madison “signed this
Agreement” and was “willing to be bound by [its] covenants” in exchange for “continued
employment” and other benefits. R.45-2 at 2, 6. It identifies Madison as an “Employee” of
Modern HC Pharmacy. A later indemnification provision is described “[a]s a condition of being
offered employment by the Company[.]” R.45-2 at 5. All in all, Madison agreed to be bound by
this agreement as an employee of Modern HC Pharmacy and its affiliates and successors.
The agreement contains three covenants that bind Madison. The first one prohibits
Madison from using or disclosing certain “materials and information of the Company or any
Affiliate.” R.45-2 at 3–4. The second one prohibits Madison, during his “employment with the
Company” and for the following year, from owning or working for a company that sells
medications in various listed areas in Tennessee and adjacent areas in nearby States. R.45-2 at 4.
The third provision prohibits Madison, during this same period and in this same geographic area,
from soliciting “any customer” or “any employee” “of the Company or any of its Affiliates.” R.45-
2 at 4. Madison agreed, then, not to disclose secrets of, compete with, or solicit
employees/customers from his employer.
The contract also anticipates new corporate ownership. It defines “the Company” to
include “any successor of the Company and any successor(s) of any such successor.” R.45-2 at 5;
R.67 at 4.
Free access — add to your briefcase to read the full text and ask questions with AI
NOT RECOMMENDED FOR PUBLICATION File Name: 24a0502n.06
Case No. 24-5513
UNITED STATES COURT OF APPEALS FOR THE SIXTH CIRCUIT
FILED Dec 06, 2024 KROGER SPECIALTY PHARMACY LA, ) KELLY L. STEPHENS, Clerk LLC; KROGER SPECIALTY PHARMACY ) HOLDINGS 2, INC., ) Plaintiffs-Appellees, ) ON APPEAL FROM THE UNITED ) STATES DISTRICT COURT FOR v. ) THE MIDDLE DISTRICT OF ) TENNESSEE GENEFIC SPECIALTY PHARMACY, INC.; ) RICHARD BROOKS MADISON, ) OPINION Defendants-Appellants.
Before: SUTTON, Chief Judge; MURPHY and BLOOMEKATZ, Circuit Judges.
SUTTON, Chief Judge. At issue is whether Richard Madison violated a noncompete
agreement with his former employer and whether his new employer, Genefic Specialty Pharmacy,
tortiously interfered with the agreement.
I.
In February 2013, a Tennessee specialty pharmacy (Total Life) hired Madison to be its
sales representative. The next year, in February 2014, another pharmacy (Modern HC Pharmacy)
purchased that company as its subsidiary.
On April 1, 2015, Madison signed a one-year noncompete and non-solicitation agreement
with Modern HC Pharmacy. The terms of the agreement prohibited Madison from competing with No. 24-5513, Kroger Specialty Pharmacies v. Genefic Specialty Pharmacy, et al.
Modern HC Pharmacy or its affiliates or successors, soliciting their customers, or recruiting their
employees.
On July 16, 2016, a Kroger-affiliated entity bought Modern HC Pharmacy. Afterward,
Modern HC Pharmacy was renamed Kroger Specialty Pharmacy Holdings 2, and its subsidiary
Total Life was renamed Kroger Specialty Pharmacy LA (referred to collectively as the Kroger
Specialty Pharmacies).
On September 15, 2023, Madison resigned. A few days later, Madison joined Genefic
Pharmacy, where he began soliciting customers of the Kroger Specialty Pharmacies and speaking
with their employees about working at Genefic Pharmacy.
Kroger learned of Madison’s activity. The Kroger Specialty Pharmacies—the successors,
recall, of Total Life and Modern HC Pharmacy—sued Madison and Genefic Pharmacy in federal
court. They raised a contract claim against Madison, a tortious-interference claim against Genefic
Pharmacy, and a trade-secrets claim against both of them.
On April 24, 2024, the district court preliminarily enjoined Madison from soliciting the
customers of the Kroger Specialty Pharmacies, recruiting their employees, or working with
Genefic Pharmacy as a representative in Tennessee, where he previously worked while employed
by the Kroger Specialty Pharmacies. The order also enjoined Genefic Pharmacy from interfering
with the agreement. Madison and Genefic Pharmacy appeal.
II.
In deciding whether to grant a preliminary injunction, courts ask whether the plaintiff is
likely to succeed, whether it will suffer irreparable harm without injunctive relief, and whether the
balance of equities and public interest favor an injunction. Winter v. Nat. Res. Def. Council, Inc.,
555 U.S. 7, 20 (2008). We review such decisions for an abuse of discretion. Arizona v. Biden, 40
2 No. 24-5513, Kroger Specialty Pharmacies v. Genefic Specialty Pharmacy, et al.
F.4th 375, 381 (6th Cir. 2022). A court abuses its discretion by misapplying the law, by using the
wrong legal standard, or by making clearly erroneous fact findings. Union Home Mortg. Corp. v.
Cromer, 31 F.4th 356, 366 (6th Cir. 2022). On appeal, Madison and Genefic Pharmacy challenge
only the district court’s likelihood-of-success determination, which we assess with fresh eyes. See
id.
As disputes about noncompete agreements go, this one has become quite narrow. None of
the conventional arguments appear. Madison and Genefic Pharmacy do not challenge the general
enforceability of the noncompete agreement. They do not argue that the provisions are unduly
restrictive in terms of duration or geographic scope. See Murfreesboro Med. Clinic, P.A. v. Udom,
166 S.W.3d 674, 678 (Tenn. 2005). They do not argue that the terms violate Tennessee public
policy. See id. They do not contest that, if the agreement applies to Madison’s actions while an
employee of Modern HC Pharmacy or its successors (the Kroger Specialty Pharmacies), he
breached the agreement. And they do not contest that, if the agreement obligates Madison vis-à-
vis the Kroger Specialty Pharmacies, that Genefic Pharmacy’s actions amounted to tortious
interference with the contract.
That leaves us with a dispute about the meaning of one aspect of the noncompete
agreement. Namely, in signing the agreement, did Madison obligate himself to Modern HC
Pharmacy and its successors, including the Kroger Specialty Pharmacies?
Tennessee law governs the dispute, as the parties agree. It says that courts, in construing a
contract, should “ascertain and give effect to the intent of the contracting parties.” Individual
Healthcare Specialists, Inc. v. BlueCross BlueShield of Tenn., Inc., 566 S.W.3d 671, 694 (Tenn.
2019). In ascertaining that intent, courts mainly look to “the written words” of the contract, “the
lodestar of contract interpretation.” Id.
3 No. 24-5513, Kroger Specialty Pharmacies v. Genefic Specialty Pharmacy, et al.
By its terms, this employment agreement binds Madison and Modern HC Pharmacy as well
as its affiliates and successors. The noncompete clause describes the employee’s and employer’s
“intent to be bound” and lists several “conditions of employment.” Vargo v. Lincoln Brass Works,
Inc., 115 S.W.3d 487, 491 (Tenn. Ct. App. 2003). The agreement says that Madison “signed this
Agreement” and was “willing to be bound by [its] covenants” in exchange for “continued
employment” and other benefits. R.45-2 at 2, 6. It identifies Madison as an “Employee” of
Modern HC Pharmacy. A later indemnification provision is described “[a]s a condition of being
offered employment by the Company[.]” R.45-2 at 5. All in all, Madison agreed to be bound by
this agreement as an employee of Modern HC Pharmacy and its affiliates and successors.
The agreement contains three covenants that bind Madison. The first one prohibits
Madison from using or disclosing certain “materials and information of the Company or any
Affiliate.” R.45-2 at 3–4. The second one prohibits Madison, during his “employment with the
Company” and for the following year, from owning or working for a company that sells
medications in various listed areas in Tennessee and adjacent areas in nearby States. R.45-2 at 4.
The third provision prohibits Madison, during this same period and in this same geographic area,
from soliciting “any customer” or “any employee” “of the Company or any of its Affiliates.” R.45-
2 at 4. Madison agreed, then, not to disclose secrets of, compete with, or solicit
employees/customers from his employer.
The contract also anticipates new corporate ownership. It defines “the Company” to
include “any successor of the Company and any successor(s) of any such successor.” R.45-2 at 5;
R.67 at 4. As a result, when the Kroger Specialty Pharmacies purchased the relevant pharmacies,
the reference to “the Company” present in all three covenants covered the succeeding Kroger
Specialty Pharmacies. That Madison worked for Total Life, its original acquirer (Modern HC
4 No. 24-5513, Kroger Specialty Pharmacies v. Genefic Specialty Pharmacy, et al.
Pharmacy), and its successor (the Kroger Specialty Pharmacies) thus does not alter his obligations
under the contract with Modern HC Pharmacy: He is bound just the same.
Other evidence confirms that the parties’ understanding of the agreement was consistent
with its language. See Seals v. Zollo, 327 S.W.2d 41, 44 (Tenn. 1959). Madison acted like an
employee of Modern HC Pharmacy. That explains why he submitted an Open Enrollment form
to it, sought employments benefits from it, and received employment benefits from it. When the
Kroger Specialty Pharmacies acquired Modern, something similar happened. They, too, treated
Madison as an employee.
In challenging this conclusion, Madison and Genefic Pharmacy maintain that “Madison
was never an employee of” Modern HC Pharmacy as opposed to his original employer, Total Life.
Appellants’ Br. 17–18. Claiming that “[p]arent companies do not automatically become the
employer of their subsidiaries’ employees,” they insist that “there is no evidence that Madison was
ever actually employed by Modern HC Pharmacy.” Appellants’ Br. 18 & n.2. But this argument
overlooks a critical reality. At a minimum, Madison became an employee of Modern HC
Pharmacy—at least for purposes of interpreting and applying the noncompete agreement—when
he signed that noncompete agreement with Modern HC Pharmacy. What other conclusion could
one draw from that act? Madison, notably, not only signed the agreement with Modern HC
Pharmacy, but he also acted like an employee of Modern HC Pharmacy, seeking and receiving
employment benefits from the company.
Madison and Genefic Pharmacy fault the district court for considering the agreement’s
context in defining its terms. But the context and language of the agreement are not at odds. They
point in the same direction—that Modern HC Pharmacy agreed to employ Madison in exchange
for his compliance with the noncompete agreement.
5 No. 24-5513, Kroger Specialty Pharmacies v. Genefic Specialty Pharmacy, et al.
Madison and Genefic Pharmacy claim that the noncompete agreement is vague when it
comes to subsidiaries. As they see it, the agreement should have defined the restricted period as
Madison’s “employment with Modern HC Pharmacy and/or its Affiliates and for one (1) year
thereafter.” Appellants’ Br. 19 n.3. But the agreement was understandable as is. Once the
agreement said that Madison worked for Modern HC Pharmacy, it had no obligation to say that he
worked for another affiliate (Total Life) before that.
Their reliance on an unpublished Delaware case also fails to give them traction. See
Frontline Techs. Parent, LLC v. Murphy, No. 2023-0546-LWW, 2023 WL 5424802 (Del. Ch.
Aug. 23, 2023). In that case, the contract failed to create an employment relationship between the
signatory and the parent company. Id. at *3. And in that case, the contract’s noncompete provision
“expressly” covered only the parent company’s “business line,” not the subsidiary’s business. Id.
at *3–4. In the course of its analysis, the court noted that the noncompete agreement would have
covered the subsidiary if the provision had included the word “Affiliates”—as Madison’s
agreement did. Id. at *5. This case, in short, supports our conclusion.
A discerning reader might wonder whether the noncompete issue has run its one-year
course, making moot any effort to enforce it today. See Mktg. Displays Int’l v. Shaw, 93 F.4th
967, 970 (6th Cir. 2024). Madison resigned in September 2023, and it has been more than one
year since then. But the agreement contains a tolling provision. It extends the length of the one-
year prohibition during any period of Madison’s noncompliance. The provision thus remains in
effect, as the parties agree. Appellants’ Supp. Br. 4–5; Kroger Supp. Br. 7.
III.
Madison and Genefic Pharmacy briefly challenge the scope of the injunction under Civil
Rule 65(d)(1) in their opening brief and do not respond to the plaintiffs’ counter-arguments in their
6 No. 24-5513, Kroger Specialty Pharmacies v. Genefic Specialty Pharmacy, et al.
reply brief. The key requirement of Rule 65(d)(1) is to ensure that the order gives “clear notice”
about what the defendants “must do or refrain from doing.” Abbott v. Perez, 585 U.S. 579, 598
(2018). The district court met this responsibility.
The key problem for Madison and Genefic Pharmacy in challenging this conclusion is that
they do not disclaim understanding how the rest of the noncompete agreement works. They argue
only whether it applied to Modern HC Pharmacy and its successors. With that uncertainty resolved
below and again on appeal, any claims about lack of “clear notice” become difficult to maintain.
Madison and Genefic Pharmacy insist that the preliminary injunction’s application to
“affiliates” is unclear. But the meaning of affiliates is not complicated. It refers to an entity that
a company controls or is controlled by. Int’l Confections Co. v. Z Cap. Grp., No. 22-3403, 2023
WL 335285, at *2 (6th Cir. Jan. 20, 2023) (collecting cases, statutes, and dictionaries). The
noncompete agreement, no surprise, defines it in the same way. The term clearly covers related
companies, whether parent companies or subsidiaries. Now that we have resolved the key legal
issue raised in the district court and here—was Madison an employee of Modern HC Pharmacy?—
it’s difficult for the two defendants to maintain that they do not understand their responsibilities
under the order.
Madison and Genefic Pharmacy add that the order is unclear when it says that Madison
cannot work for Genefic Pharmacy in Tennessee in the “‘therapeutic areas’ he represented while
employed by” Modern HC Pharmacy, its affiliates, or its successors. R.74 at 2. But surely
Madison knows the therapeutic areas in which he worked before joining Genefic Pharmacy. Given
the extensive proceedings below, Madison’s understanding of his own work before joining Genefic
Pharmacy, the defendants’ possession of the noncompete agreement from the outset, two federal
courts’ consistent interpretations of it, and the failure of Madison or Genefic Pharmacy to seek any
7 No. 24-5513, Kroger Specialty Pharmacies v. Genefic Specialty Pharmacy, et al.
clarifications below on these points, it is fair to conclude that they fully understand their obligations
under it. If, at any rate, some other ambiguity emerges, they remain free to return to the district
court, whose power to “modify a decree of injunctive relief is long-established, broad, and
flexible.” Brown v. Plata, 563 U.S. 493, 542 (2011) (quotation omitted).
We affirm.